
Challenging sequential approach to treatment resistant depression: Cost-utility analysis based on the Sequenced Treatment Alternatives to Relieve Depression (STARâD) trial
Keywords: سود; Depression; Antidepressants; Pharmacoeconomics; Cost-benefit; Switching;